The FDA has cleared the newest version of the non-invasive ExSpironTM Minute Ventilation Monitor which does not require calibration.
Minute Ventilation (MV) is the earliest indicator of insufficient breathing, and the ExSpiron is the first and only device to provide accurate MV measurements continuously and non-invasively.
This new version of the ExSpiron greatly expands the clinical usefulness of the ExSpiron… now assessing breathing and helping to direct care in seconds, “anytime, anywhere”.
Waltham, Mass. (October 17, 2017) – Respiratory Motion, Inc., announced today its plans to launch the newest version of its ExSpiron 1Xi™ Minute Ventilation (MV) Monitor at the American Society of Anesthesiologists (ASA) in Boston, October 21-25 following recent FDA 510(k) clearance. This new ExSpiron requires no calibration, which greatly expands its range of use. Physicians, nurses, respiratory therapists, EMT’s and first responders can now easily assess and measure a patients breathing in seconds.